PATENT CLAIM ANALYSIS

Application Number: 15882767
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "008100"]

Abstract:
The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.

Claim (Index 11):
The method of  claim 10 , wherein an increase in cardiac function is indicated by increased cardiac output, reduced left ventricular end diameter during diastole (LVEDD), improves echocardiography scoring for wall motion, increases the difference in left ventricle anterior wall thickness between diastole and systole, or improves percent fractional shortening.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13220555', '14826613', '14771747', '15623025', '15553505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8532357767541238
- 35 USC 102 Novelty (BERT): 0.6081016533256166
- Combined Prediction Score: 0.8287223644112731
- Mean Citation Score: 544.049848
- Max Citation Score: 818.1908
- Similarity Product: 466.18484612545967

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test